<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a retrospective study of 236 patients with primary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 130 cases (55.1%) revealed <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> in bone marrow biopsies </plain></SENT>
<SENT sid="1" pm="."><plain>It was observed that <z:mp ids='MP_0003045'>fibrosis</z:mp> mostly occurs focally or patchy, and collagen deposits were found very rarely (only four patients) </plain></SENT>
<SENT sid="2" pm="."><plain>The histopathology of bone marrow biopsies revealed several differences between fibrotic and non-fibrotic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>: cellularity is significantly higher, dysmegakaryopoiesis is more pronounced, plasmocytes and mast cells are more often increased, and disturbance of marrow topography (particularly of the MK- and G-line) can be found more frequently in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Reticulin <z:mp ids='MP_0003045'>fibrosis</z:mp> occurred in <z:hpo ids='HP_0000001'>all</z:hpo> subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; however, there was a higher incidence in <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The frequency of abnormal growth of GM-progenitors was significantly higher in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, compared to the cases without <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical data showed significantly higher WBC, more frequent presence of immature granulocytes, and higher percentage of myeloblasts in peripheral blood and bone marrow in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> compared to cases without <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Life expectancy was reduced to 13 mo, compared with 35 mo in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> without <z:mp ids='MP_0003045'>fibrosis</z:mp> (p=0.00055) </plain></SENT>
<SENT sid="7" pm="."><plain>Time to leukemic transformation was 32 mo in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:mp ids='MP_0003045'>fibrosis</z:mp>, compared with &gt;56 mo in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> without <z:mp ids='MP_0003045'>fibrosis</z:mp> (p=0.015) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0011974'>Myelofibrosis</z:hpo> therefore seems to herald a poor prognosis </plain></SENT>
</text></document>